Cardiex Ltd - Asset Resilience Ratio
Cardiex Ltd (CDX) has an Asset Resilience Ratio of 0.16% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Cardiex Ltd (CDX) strategic investment index to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2002–2024)
This chart shows how Cardiex Ltd's Asset Resilience Ratio has changed over time. See net asset quality index of Cardiex Ltd to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Cardiex Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see CDX stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 0% |
| Short-term Investments | AU$27.98K | 0.16% |
| Total Liquid Assets | AU$27.98K | 0.16% |
Asset Resilience Insights
- Limited Liquidity: Cardiex Ltd maintains only 0.16% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Cardiex Ltd Industry Peers by Asset Resilience Ratio
Compare Cardiex Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Inspire Medical Systems Inc
NYSE:INSP |
Medical Devices | 20.29% |
|
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186 |
Medical Devices | 0.84% |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033 |
Medical Devices | 19.31% |
|
Stratec SE
XETRA:SBS |
Medical Devices | 0.30% |
|
Duearity AB
ST:DEAR |
Medical Devices | 145.62% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
Annual Asset Resilience Ratio for Cardiex Ltd (2002–2024)
The table below shows the annual Asset Resilience Ratio data for Cardiex Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-06-30 | 38.50% | AU$4.87 Million ≈ $3.45 Million |
AU$12.65 Million ≈ $8.95 Million |
-0.36pp |
| 2023-06-30 | 38.86% | AU$5.56 Million ≈ $3.93 Million |
AU$14.30 Million ≈ $10.12 Million |
+30.43pp |
| 2022-06-30 | 8.43% | AU$1.04 Million ≈ $738.22K |
AU$12.38 Million ≈ $8.76 Million |
-5.20pp |
| 2021-06-30 | 13.63% | AU$1.54 Million ≈ $1.09 Million |
AU$11.26 Million ≈ $7.97 Million |
+6.81pp |
| 2020-06-30 | 6.82% | AU$728.54K ≈ $515.49K |
AU$10.68 Million ≈ $7.55 Million |
+46.59pp |
| 2019-06-30 | -39.77% | AU$-5.25 Million ≈ $-3.72 Million |
AU$13.21 Million ≈ $9.35 Million |
-- |
| 2017-06-30 | 0.00% | AU$0.00 ≈ $0.00 |
AU$2.96 Million ≈ $2.09 Million |
-- |
| 2016-06-30 | 0.00% | AU$0.00 ≈ $0.00 |
AU$4.60 Million ≈ $3.26 Million |
-- |
| 2003-06-30 | 0.97% | AU$15.00K ≈ $10.61K |
AU$1.54 Million ≈ $1.09 Million |
+0.01pp |
| 2002-06-30 | 0.96% | AU$15.00K ≈ $10.61K |
AU$1.56 Million ≈ $1.10 Million |
-- |
About Cardiex Ltd
Conneqt Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffnes… Read more